Pharmaceutical compositions for the treatment of infections of the respiratory system by pathogenic agents
The present invention relates to pharmaceutical compositions for the treatment of infections by pathogen agents of the respiratory system, for example Staphylococcus aureus , and more particularly it relates to the aforesaid compositions containing N-acetyl-cysteine possibly combined with thiamphenicol.
1 . A process for preparing a pharmaceutical composition containing N-acetyl-cysteine for the preventive or disruptive treatment of biofilms produced by Staphylococcus aureus and by other pathogen agents of the respiratory system.
2 . A process for preparing a pharmaceutical composition containing thiamphenicol useful for increasing the activity of N-acetyl-cysteine in inhibiting or disrupting the biofilm produced by Staphylococcus aureus and by other pathogen agents of the respiratory system.
3 . A pharmaceutical composition containing N-acetyl-cysteine and thiamphenicol and use thereof in inhibiting or disrupting biofilms produced by Staphylococcus aureus and by other pathogen agents of the respiratory system.
4 . A process for preparing a pharmaceutical composition containing thiamphenicol glycinate acetylcysteinate useful for inhibiting or disrupting biofilms produced by Staphylococcus aureus and by other pathogen agents of the respiratory system.